Fighting Mycobacterium tuberculosis with structural proteomics

Tuberculosis is one of the deadliest threats to public health today. An estimated two billion people are infected with Mycobacterium tuberculosis (Mtb), with eight million new cases annually and two million people dying from the infection each year. The situation is further aggravated by the lethal alliance of HIV and Mtb co-infection. HIV patients have weakened immune systems, making them more susceptible to secondary infections and about one-third of HIV patients die from tuberculosis.

The most effective Mtb-specific antibiotics were developed more than thirty years ago, and since that time, the bacterium has learned to defend itself to become resistant to many of the current drugs. The great need for effective drugs has led researchers at the European Molecular Biology Laboratory (EMBL) Hamburg Outstation and a mix of academic and industrial collaborators to study the proteins in the bacterium, which are the functional machines behind the tuberculosis. By studying the structures of these proteins, an approach termed 'structural proteomics', they hope to find more effective drugs against Mtb.

In support of their efforts, the German Federal Ministry of Education and Research has now awarded a 3.5 million Euro grant as part of the government's proteomics initiative "New efficient procedures for functional proteome analysis". The project will be coordinated by EMBL Hamburg and comprises three additional academic partners (Max-Planck Groups for Molecular Structural Biology, Hamburg; Max-Planck-Institute for Infectious Biology, Berlin; Technical University of Munich, Research Center Weihenstefan) and three industrial partners (Biomax, Martinsried; Combinature, Berlin; MarResearch, Norderstedt).

EMBL Hamburg and their partners will work together to apply a step-by-step, structure-based approach to this drug discovery oriented process. In a novel approach, the Max-Planck-Institute for Infectious Biology, Berlin, will analyse the expression of Mtb

Contact: Trista Dawson
European Molecular Biology Laboratory

Page: 1 2 3

Related biology news :

1. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
2. Fighting the spread of sudden oak death
3. Fighting the battle of the bulge in children
4. Fighting breast cancer at the molecular level
5. Fighting Fungi
6. Fighting skin cancers with computers and technology
7. Fighting diabetes: UD researchers move closer to chip-based control of smart, implantable insulin pumps
8. Trash From Crop-Processing Plant Harvested For Disease-Fighting Agents
9. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
10. Chemical Contaminants May Inhibit Cancer-Fighting White Blood Cells
11. Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats

Post Your Comments:

(Date:7/22/2020)... , ... July 21, 2020 , ... ... transformation and innovation in technology and compliance, announces a new solution to manage ... must ensure every layer of their technology stack complies with FDA and global ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While ... global economic downturn will only increase price pressures overall for the industry. The era ... from every product launch is critical. However, history shows that only a third of ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from ... Sr. Manager Regulatory Solutions, in a one hour live webinar on Thursday, ... body in China for drugs and medical devices. Specifically, for medical devices, the NMPA ...
Breaking Biology Technology:
Cached News: